4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide
C17H20FN7OS — CID 156888612
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide
4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide (PubChem CID 156888612) has the molecular formula C17H20FN7OS and a molecular weight of 389.46 g/mol. Its IUPAC name is 4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide.
Molecular Properties
| Compound Name | 4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide |
|---|---|
| PubChem CID | 156888612 |
| Molecular Formula | C17H20FN7OS |
| Molecular Weight | 389.46 g/mol |
| Exact Mass | 389.14 |
| IUPAC Name | 4-amino-N-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide |
| SMILES | Cc1cn2cc(NC(=O)c3sc(N4CCN(C)CC4)nc3N)cc(F)c2n1 |
| InChI | InChI=1S/C17H20FN7OS/c1-10-8-25-9-11(7-12(18)15(25)20-10)21-16(26)13-14(19)22-17(27-13)24-5-3-23(2)4-6-24/h7-9H,3-6,19H2,1-2H3,(H,21,26) |
| InChIKey | LBACQRGKWZXFTF-UHFFFAOYSA-N |
| XLogP | 1.82 |
| TPSA | 91.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.46 |
| LogP ≤ 5 | 1.82 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156888612 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.